Reduces Blood Pressure Linked to mild reductions in blood pressure, benefitting both type 2 diabetes patients and those at risk of heart disease
You should seek urgent medical advice if you experience severe or ongoing stomach pain, repeated vomiting, signs of dehydration, symptoms of an allergic reaction, or if you feel seriously unwell
Report any side effects, changes in appetite, or weight changes so your provider can adjust your dose or provide supportive guidance
De la Rosa, A
The table shows that resmetirom is a small (molecular weight about 600 g/mol), non-iodinated THR- agonist administered once daily as an oral tablet, while semaglutide is a large (about 4 kDa) GLP-1 peptide designed for once-weekly subcutaneous injection or, with SNAC enhancement, once-daily oral administration